Contact this trialFirst, we need to learn more about you.
Anticoagulant
Enoxaparin Dosing Regimens for Blood Clots
Recruiting3 awardsPhase 4
Portland, Oregon
This trial will help determine if a lower dose of enoxaparin given twice daily is as effective as the standard dose of enoxaparin given once daily in preventing blood clots in critically ill patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.